Cytokinetics CYTK
NASDAQ CYTK
$65.60 -0.02 (-0.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Price to Earnings (2016 - 2017)

Updated

Cytokinetics' Price to Earnings was 183.46 in Q1 2017, up 511.2% from the prior quarter.

Analysis

Cytokinetics (CYTK) Price to Earnings (2016 - 2017) Analysis & Trends

For FY2016, Price to Earnings at Cytokinetics came in at 30.02.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cytokinetics 9.12 Bn 5.29 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 183.46
Dec 31, 2016 30.02
Sep 30, 2016 5,551.42
API Access

Cytokinetics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CYTK&period=max&api_key=YOUR_API_KEY